190 related articles for article (PubMed ID: 27730471)
1. Monitoring Tumor Response after Liposomal Doxorubicin in Combination with Liposomal Vinorelbine Treatment Using 3'-Deoxy-3'-[
Wu CY; Tang JH; Chan PC; Li JJ; Lin MH; Shen CC; Liu RS; Wang HE
Mol Imaging Biol; 2017 Jun; 19(3):408-420. PubMed ID: 27730471
[TBL] [Abstract][Full Text] [Related]
2. Monitoring tumor response with [18F]FMAU in a sarcoma-bearing mouse model after liposomal vinorelbine treatment.
Chan PC; Wu CY; Chang WT; Lin CY; Tseng YL; Liu RS; Alauddin MM; Lin WJ; Wang HE
Nucl Med Biol; 2013 Nov; 40(8):1035-42. PubMed ID: 23969084
[TBL] [Abstract][Full Text] [Related]
3. Monitoring tumor response with radiolabeled nucleoside analogs in a hepatoma-bearing mouse model early after doxisome(®) treatment.
Wu CY; Chou LS; Chan PC; Ho CH; Lin MH; Shen CC; Liu RS; Lin WJ; Wang HE
Mol Imaging Biol; 2013 Jun; 15(3):326-35. PubMed ID: 23247923
[TBL] [Abstract][Full Text] [Related]
4. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy evaluation of 111In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Pang VF; Liu RS; Lin WJ; Yang CS; Ting G
J Nucl Med; 2009 Dec; 50(12):2073-81. PubMed ID: 19949027
[TBL] [Abstract][Full Text] [Related]
6. Early detection of tumor response by FLT/microPET Imaging in a C26 murine colon carcinoma solid tumor animal model.
Lee WC; Chang CH; Ho CL; Chen LC; Wu YH; Chen JT; Wang YL; Lee TW
J Biomed Biotechnol; 2011; 2011():535902. PubMed ID: 21869861
[TBL] [Abstract][Full Text] [Related]
7. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H
Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694
[TBL] [Abstract][Full Text] [Related]
8. Response Monitoring with [
Heskamp S; Heijmen L; Gerrits D; Molkenboer-Kuenen JDM; Ter Voert EGW; Heinzmann K; Honess DJ; Smith DM; Griffiths JR; Doblas S; Sinkus R; Laverman P; Oyen WJG; Heerschap A; Boerman OC
Mol Imaging Biol; 2017 Aug; 19(4):540-549. PubMed ID: 27798786
[TBL] [Abstract][Full Text] [Related]
9. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Efficacy of the Combination of Berberine and PEGylated Liposomal Doxorubicin in Meth A Sarcoma-Bearing Mice.
Yahuafai J; Asai T; Oku N; Siripong P
Biol Pharm Bull; 2018; 41(7):1103-1106. PubMed ID: 29962406
[TBL] [Abstract][Full Text] [Related]
11. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with
Chan SR; Salem K; Jeffery J; Powers GL; Yan Y; Shoghi KI; Mahajan AM; Fowler AM
J Nucl Med; 2018 May; 59(5):833-838. PubMed ID: 29217733
[TBL] [Abstract][Full Text] [Related]
12. [
Kim SY; Jung JH; Lee HJ; Soh H; Lee SJ; Oh SJ; Chae SY; Lee JH; Lee SJ; Hong YS; Kim TW; Moon DH
Cancer Res; 2017 Dec; 77(24):7120-7130. PubMed ID: 29055019
[TBL] [Abstract][Full Text] [Related]
13. Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models.
Fleuren ED; Versleijen-Jonkers YM; Roeffen MH; Franssen GM; Flucke UE; Houghton PJ; Oyen WJ; Boerman OC; van der Graaf WT
Int J Cancer; 2014 Dec; 135(12):2770-82. PubMed ID: 24771207
[TBL] [Abstract][Full Text] [Related]
14. In vivo imaging of therapy response to a novel pan-HER antibody mixture using FDG and FLT positron emission tomography.
Nielsen CH; Jensen MM; Kristensen LK; Dahlman A; Fröhlich C; Jacobsen HJ; Poulsen TT; Lantto J; Horak ID; Kragh M; Kjaer A
Oncotarget; 2015 Nov; 6(35):37486-99. PubMed ID: 26460961
[TBL] [Abstract][Full Text] [Related]
15. 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer.
Zannetti A; Iommelli F; Speranza A; Salvatore M; Del Vecchio S
J Nucl Med; 2012 Mar; 53(3):443-50. PubMed ID: 22331221
[TBL] [Abstract][Full Text] [Related]
16. Delineating the anti-metastatic potential of pentoxifylline in combination with liposomal doxorubicin against breast cancer cells.
Goel PN; Gude RP
Biomed Pharmacother; 2014 Mar; 68(2):191-200. PubMed ID: 24373697
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of Early-Stage Uptake of 3'-Deoxy-3'-18F-Fluorothymidine in Cancer Cells Treated with Charged Particle Irradiation.
Lin C; Kume K; Mori T; Martinez ME; Okazawa H; Kiyono Y
J Nucl Med; 2015 Jun; 56(6):945-50. PubMed ID: 25766892
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography imaging of human colon cancer xenografts in mice with [18F]fluorothymidine after TAS-102 treatment.
Lee HJ; Oh SJ; Lee EJ; Chung JH; Kim Y; Ryu JS; Kim SY; Lee SJ; Moon DH; Kim TW
Cancer Chemother Pharmacol; 2015 May; 75(5):1005-13. PubMed ID: 25776904
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Efficacy Evaluation of Pegylated Liposome Encapsulated With Vinorelbine Plus
Chien YC; Chou YH; Wang WH; Chen JC; Chang WS; Tsai CW; Bau DT; Hwang JJ
Cancer Genomics Proteomics; 2020; 17(1):61-76. PubMed ID: 31882552
[TBL] [Abstract][Full Text] [Related]
20. [18F]FLT PET for non-invasive assessment of tumor sensitivity to chemotherapy: studies with experimental chemotherapy TP202377 in human cancer xenografts in mice.
Munk Jensen M; Erichsen KD; Björkling F; Madsen J; Jensen PB; Sehested M; Højgaard L; Kjær A
PLoS One; 2012; 7(11):e50618. PubMed ID: 23226334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]